Results 251 to 260 of about 187,908 (321)

Cytokines and Brain-Derived Neurotrophic Factor as Biomarkers of Cognitive Impairment Related to Breast Cancer and Its Treatments: A Systematic Review. [PDF]

Int J Mol Sci
Fierro-Salgado YT, Reiriz M, Beltrán-Velasco AI, Calleja-Conde J, Hernández-Oñativia X, Uceda S, Echeverry-Alzate V.   +6 more
europepmc   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

A single oral administration of flavanols enhances short-term memory in mice along with increased brain-derived neurotrophic factor. [PDF]

Open Med (Wars)
Fujii Y, Yamato Y, Shibata M, Takano K, Tsuchibuchi S, Taira S, Calabrese V, Osakabe N.   +7 more
europepmc   +1 more source

Brain-derived neurotrophic factor as a target for the search of anti-addiction drugs

M. S. Khalimanov, Ekaterina Grigorevskikh, K. A. Zavadich, Sergey I. Sologov, D. A. Traschenkova, Kristina Tatzhikova, Eugenia Polikarpov, Susanna S. Sologova, D.А. Kudlаy, Е. А. Smolyarchuk   +9 more
openalex   +2 more sources

Brain‐derived neurotrophic factor is required for normal development of the central respiratory rhythm in mice

, 1998
Agnieszka Bałkowiec, David M. Katz
openalex   +1 more source

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source

Exploring Salivary Brain-Derived Neurotrophic Factor (BDNF) as a Potential Biomarker of Neuroplasticity in Older Adults Through Exergaming. [PDF]

Cureus
Pistritto SC, Burhan AM, Chiu M, Elgazzar S, Lally P, Sun W.   +5 more
europepmc   +1 more source

Nicotine-Induced Effects on Nicotinic Acetylcholine Receptors (nAChRs), Ca2+ and Brain-Derived Neurotrophic Factor (BDNF) in STC-1 Cells

, 2016
Jie Qian, Shobha Mummalaneni, Reem Alkahtani, Sunila Mahavadi, Karnam S. Murthy, John R. Grider, Vijay Lyall   +6 more
openalex   +2 more sources

Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT2A receptor agonists

British Journal of Pharmacology, EarlyView.
Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because of their association with counterculture movements and a perceived concern about harm through recreational use, and their consequent legal prohibition in the early 1970s.
Trevor Sharp, Aurelija Ippolito
wiley   +1 more source

A comparison of commercial assays quantifying mature brain-derived neurotrophic factor (mBDNF) and its precursor (pro-BDNF) in human serum. [PDF]

Sci Rep
Olivas-Martínez A, Peinado FM, Pérez-Cantero A, Espín-Moreno L, Rodríguez-Carrillo A, García-Esquinas E, Olea N, Mustieles V, Fernández MF.   +8 more
europepmc   +1 more source